Log in to save to my catalogue

Developing Antiangiogenic Peptide Drugs for Angiogenesis-Related Diseases

Developing Antiangiogenic Peptide Drugs for Angiogenesis-Related Diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70692115

Developing Antiangiogenic Peptide Drugs for Angiogenesis-Related Diseases

About this item

Full title

Developing Antiangiogenic Peptide Drugs for Angiogenesis-Related Diseases

Author / Creator

Publisher

United Arab Emirates: Bentham Science Publishers Ltd

Journal title

Current pharmaceutical design, 2007-07, Vol.13 (20), p.2074-2086

Language

English

Formats

Publication information

Publisher

United Arab Emirates: Bentham Science Publishers Ltd

More information

Scope and Contents

Contents

Angiogenesis is regulated by stimulators and inhibitors and involve multiple biological processes including endothelial cell proliferation, migration, cell-cell and cell-matrix adhesion, assembly into tube structures as well as apoptosis. Designing and developing peptides for therapeutic application to inhibit angiogenesis is an important area in a...

Alternative Titles

Full title

Developing Antiangiogenic Peptide Drugs for Angiogenesis-Related Diseases

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_70692115

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70692115

Other Identifiers

ISSN

1381-6128

E-ISSN

1873-4286

DOI

10.2174/138161207781039715

How to access this item